N-myc Downstream Regulated Gene 1 Increases Differentiation Factors Level in Human Prostate Cancer Cells without Affecting Cell Proliferation and Cell Cycle Profiles

Tina Napso, Naiel Azzam, Aaron Lerner, Fuad Fares

Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Department of Molecular Genetics, Carmel Medical Center, Haifa, Israel.
Pediatric Gastroenterology and Nutrition Unit, Carmel Medical Center, Haifa, Israel.

DOI: 10.4236/jct.2013.42072                

Abstract

N-myc downstream regulated gene 1 (NDRG1), also known as differentiation related gene 1, was previously identified as an up-regulated gene upon cellular differentiation. Even though its sequence along with its expressional pattern in cancer cell lines are evident, the functional aspects concerning cell proliferation, viability, differentiation and cell cycle regulation of NDRG1 remains vague. The aim of the present study was to elucidate the functional role of NDRG1 in human prostate cancer. Our results showed basal levels of NDRG1 expression in PC-3 (poorly differentiated, null p53), DU-145 (moderately differentiated, mutant p53) and LNCaP (well-differentiated, wiled type p53). Nevertheless, NDRG1 sequencing assay disclosed no mutations in the gene. Furthermore, human cDNA of NDRG1 from normal placenta was cloned into a eukaryotic expression vector and transfected into the three cancer cell lines. This resulted in over-expression of NDRG1, which in turn markedly up regulated two differentiation markers of the prostate tissue, p21 and cytokeratin 8/18. Unpredictably, cell cycle progression, cell proliferation and DNA synthesis were unaffected following NDRG1 expression. These results revealed that NDRG1 is functional in prostate cancer cells and able to induce expression of differentiation factors through p53 independent pathway. However, the pathway downstream NDRG1, involving p21 and c8/18, regulating cell cycle progression and DNA synthesis is unfunctional. Loss of sensitivity to p21 cell cycle control may be associated with prostatic cancer behavior. Further studies are required to clarify the intra cellular molecular pathways affecting NDRG1 function in human prostate cancer.

Keywords

NDRG1; Human Prostate Cancer; p21; Cytokeratin 8/18

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	N. van Belzen, W. N. Dinjens, M. P. Diesveld, N. A. Groen, A. C. van der Made, Y. Nozawa, et al., “A Novel Gene Which Is Up-Regulated during Colon Epithelial Cell Differentiation and Down-Regulated in Colorectal Neoplasms,” Laboratory Investigation: A Journal of Technical Methods and Pathology, Vol. 77, No. 1, 1997, pp. 85-92.
[2]	N. van Belzen, W. N. Dinjens, B. H. Eussen and F. T. Bosman, “Expression of Differentiation-Related Genes in Colorectal Cancer: Possible Implications for Prognosis,” Histology and Histopathology, Vol. 13, No. 4, 1998, pp. 1233-1242.
[3]	K. L. Agarwala, K. Kokame, H. Kato and T. Miyata, “Phosphorylation of RTP, an ER Stress-Responsive Cytoplasmic Protein,” Biochemical and Biophysical Research Communications, Vol. 272, No. 3, 2000, pp. 641-647. doi:10.1006/bbrc.2000.2833
[4]	R. H. Zhou, K. Kokame, Y. Tsukamoto, C. Yutani, H. Kato and T. Miyata, “Characterization of the Human NDRG Gene Family: A Newly Identified Member, NDRG4, Is Specifically Expressed in Brain and Heart,” Genomics, Vol. 73, No. 1, 2001, pp. 86-97. doi:10.1006/geno.2000.6496
[5]	T. Okuda and H. Kondoh, “Identification of New Genes ndr2 and ndr3 Which Are Related to Ndr1/RTP/Drg1 but Show Distinct Tissue Specificity and Response to Nmyc,” Biochemical and Biophysical Research Communications, Vol. 266, No. 1, 1999, pp. 208-215. doi:10.1006/bbrc.1999.1780
[6]	D. Zhou, K. Salnikow and M. Costa, “Cap43, a Novel Gene Specifically Induced by Ni2+ Compounds,” Cancer Research, Vol. 58, No. 10, 1998, pp. 2182-2189.
[7]	K. Kokame, H. Kato and T. Miyata, “Homocysteine-Respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis. GRP78/BiP and Novel Genes,” The Journal of Biological Chemistry, Vol. 271, No. 47, 1996, pp. 29659-29665. doi:10.1074/jbc.271.47.29659
[8]	H. Park, M. A. Adams, P. Lachat, F. Bosman, S. C. Pang and C. H. Graham, “Hypoxia Induces the Expression of a 43-kDa Protein (PROXY-1) in Normal and Malignant Cells,” Biochemical and Biophysical Research Communications, Vol. 276, No. 1, 2000, pp. 321-328. doi:10.1006/ bbrc.2000.3475
[9]	W. Ulrix, J. V. Swinnen, W. Heyns and G. Verhoeven, “The Differentiation-Related Gene 1, Drg1, Is Markedly Upregulated by Androgens in LNCaP Prostatic Adenocarcinoma Cells,” FEBS Letters, Vol. 455, No. 1-2, 1999, pp. 23-26. doi:10.1016/S0014-5793(99)00845-5
[10]	R. J. Guan, H. L. Ford, Y. Fu, Y. Li, L. M. Shaw and A. B. Pardee, “Drg-1 as a Differentiation-Related, Putative Metastatic Suppressor Gene in Human Colon Cancer,” Cancer Research, Vol. 60, No. 3, 2000 , pp. 749-755.
[11]	S. Bandyopadhyay, S. K. Pai, S. C. Gross, S. Hirota, S. Hosobe, K. Miura, et al., “The Drg-1 Gene Suppresses Tumor Metastasis in Prostate Cancer,” Cancer Research, Vol. 63, No. 8, 2003, pp. 1731-1736.
[12]	S. Bandyopadhyay, S. K. Pai, S. Hirota, S. Hosobe, Y. Takano, K. Saito, et al., “Role of the Putative Tumor Metastasis Suppressor Gene Drg-1 in Breast Cancer Progression,” Oncogene, Vol. 23, No. 33, 2004, pp. 5675-5681. doi:10.1038/sj.onc.1207734
[13]	N. van Belzen, W. N. Dinjens, M. P. Diesveld, N. A. Groen, A. C. van der Made, Y. Nozawa, et al., “A Novel Gene Which Is Up-Regulated during Colon Epithelial Cell Differentiation and down-regulated in Colorectal Neoplasms,” Laboratory Investigation, Vol. 77, No. 1, 1997, pp. 85-92.
[14]	T. Okuda, Y. Higashi, K. Kokame, C. Tanaka, H. Kondoh and T. Miyata, “Ndrg1-Deficient Mice Exhibit a Progressive Demyelinating Disorder of Peripheral Nerves,” Molecular and Cellular Biology, Vol. 24, No. 9, 2004, pp. 3949-3956. doi:10.1128/MCB.24.9.3949-3956.2004
[15]	S. Stein, E. K. Thomas, B. Herzog, M. D. Westfall, J. V. Rocheleau, R. S. Jackson 2nd, et al., “NDRG1 Is Necessary for p53-Dependent Apoptosis,” The Journal of Biological Chemistry, Vol. 279, No. 47, 2004, pp. 48930-48940. doi:10.1074/jbc.M400386200
[16]	R. J. Guan, H. L. Ford, Y. Fu, Y. Li, L. M. Shaw and A. B. Pardee, “Drg-1 as a Differentiation-Related, Putative Metastatic Suppressor Gene in Human Colon Cancer,” Cancer Research, Vol. 60, No. 3, 2000, pp. 749-755.
[17]	E. R. Sherwood, G. Theyer, G. Steiner, L. A. Berg, J. M. Kozlowski and C. Lee, “Differential Expression of Specific Cytokeratin Polypeptides in the Basal and Luminal Epithelia of the Human Prostate,” The Prostate, Vol. 18, No. 4, 1991, pp. 303-314. doi:10.1002 /pros.2990180404
[18]	K. Salnikow, M. V. Blagosklonny, H. Ryan, R. Johnson and M. Costa, “Carcinogenic Nickel Induces Genes Involved with Hypoxic Stress,” Cancer Research, Vol. 60, No. 1, 2000, pp. 38-41.
[19]	K. Fizazi, L. A. Martinez, C. R. Sikes, D. A. Johnston, L. C. Stephens, T. J. McDonnell, et al., “The Association of p21((WAF-1/CIP1)) with Progression to Androgen-Independent Prostate Cancer,” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, Vol. 8, No. 3, 2002, pp. 775-781.